Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 896-899, February 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, B. D.
Right arrow Articles by Park, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, B. D.
Right arrow Articles by Park, S. J.

DNA Damage Increases the Levels of MDM2 Messenger RNA in wtp53 Human Cells1

Brendan D. Price2 and Sonia J. Park

Stress Protein Group, Joint Center for Radiation Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts 02115

2 To whom requests for reprints should be addressed, at Joint Center for Radiation Therapy, 50 Binney St., Boston, MA 02115.

Damage to chromosomal DNA increases the levels of the transcriptional regulatory protein p53. We have investigated how the MDM2 protein, which binds to p53 and inactivates its transcriptional activity, may be controlled following DNA damage. Irradiation of human GM2149 fibroblast cells causes an increase in MDM2 mRNA levels within 1 h, and levels remain elevated for at least 8 h. The induction of MDM2 mRNA following irradiation is not blocked by inhibitors of protein synthesis and can be detected after doses of 2-5 Gy. In ataxia telangiectasia cells or cells where p53 is mutated/deleted, MDM2 mRNA levels are not increased after DNA damage. This suggests that p53 is required for transcription of the MDM2 gene following DNA damage.

1 Supported by funds from the Joint Center for Radiation Therapy.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/17/93. Accepted 1/ 5/94.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
S. P. Deb
Cell Cycle Regulatory Functions of the Human Oncoprotein MDM2
Mol. Cancer Res., December 1, 2003; 1(14): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Wani, Q. Zhu, M. El-Mahdy, S. Venkatachalam, and A. A. Wani
Enhanced Sensitivity to anti-Benzo(a)pyrene-diol-epoxide DNA Damage Correlates with Decreased Global Genomic Repair Attributable to Abrogated p53 Function in Human Cells
Cancer Res., April 1, 2000; 60(8): 2273 - 2280.
[Abstract] [Full Text]


Home page
BloodHome page
M. Urashima, G. Teoh, D. Chauhan, A. Ogata, S. Shirahama, C. Kaihara, M. Matsuzaki, H. Matsushima, M. Akiyama, Y. Yuza, et al.
MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor-Dependent Acute Myeloblastic Leukemia Cells
Blood, August 1, 1998; 92(3): 959 - 967.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
E. Perz and J. G. Kuhn
Review : p53 in the pathogenesis, diagnosis, and treatment of cancer
Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Leveillard and B. Wasylyk
The MDM2 C-terminal Region Binds to TAFII250 and Is Required for MDM2 Regulation of the Cyclin A Promoter
J. Biol. Chem., December 5, 1997; 272(49): 30651 - 30661.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Teoh, M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson
MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells
Blood, September 1, 1997; 90(5): 1982 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. N. Jones, A. T. Sands, A. R. Hancock, H. Vogel, L. A. Donehower, S. P. Linke, G. M. Wahl, and A. Bradley
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2
PNAS, November 26, 1996; 93(24): 14106 - 14111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Beamish, R. Williams, P. Chen, and M. F. Lavin
Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
J. Biol. Chem., August 23, 1996; 271(34): 20486 - 20493.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Hartwell and M. Kastan
Cell cycle control and cancer
Science, December 16, 1994; 266(5192): 1821 - 1828.
[Abstract] [PDF]


Home page
Genes Dev.Home page
A Di Leonardo, S P Linke, K Clarkin, and G M Wahl
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
Genes & Dev., November 1, 1994; 8(21): 2540 - 2551.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Hsing, D. V. Faller, and C. Vaziri
DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms
J. Biol. Chem., August 18, 2000; 275(34): 26024 - 26031.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.